Demographic and clinical data | COVID-19 Era | p value | ||
---|---|---|---|---|
Group (1) (n = 441) | Group (2) (n = 679) | Group (3) (n = 285) | ||
Age (years) (mean ± SD) | 47.7 ± 18.3 | 50.9 ± 18.1 | 49.8 ± 17.7 | 0.01* |
Sex | Â | Â | Â | Â |
 Male | 171 (29.6%) | 283 (48.2%) | 133 (22.7%) | 0.1 |
 Female | 270 (32%) | 396 (48.4%) | 152 (18.6%) | |
Risk factors and comorbidities | ||||
 DM | ||||
  Yes | 101 (22.9%) | 155 (45.5%) | 85 (24.9%) | 0.05* |
  No | 340 (77.1%) | 524 (49.2%) | 200 (18.8%) | |
 HTN | ||||
  Yes | 138 (30.5%) | 209 (46.2%) | 105 (23.2%) | 0.2 |
  No | 303 (31.8%) | 470 (49.3%) | 180 (18.9%) | |
 Cardiac | ||||
  Yes | 68 (28.5%) | 119 (49.8%) | 52 (21.8%) | 0.4 |
  No | 373 (33%) | 526 (46.5%) | 233 (20.6%) | |
 HCV | ||||
  Yes | 77 (33.9%) | 107 (47.1%) | 43 (18.9%) | 0.7 |
  No | 364 (31.9%) | 535 (46.9%) | 242 (21.2%) | |
 Smoking | ||||
  Yes | 101 (26.1%) | 204 (52.7%) | 82 (21.2%) | 0.006* |
  No | 340 (34.7%) | 438 (44.6%) | 203 (20.7%) | |
 Pregnancy | ||||
  No | 258 (33.9%) | 361 (47.5%) | 141 (18.6%) | 0.09 |
  Yes | 12 (20.7%) | 35 (60.3%) | 11 (19%) | |
Initial COVID-19 presentation | ||||
 Fever | – | 126 (66%) | 65 (34%) | 0.2 |
 Respiratory | – | 33 (71.1%) | 13 (28.3%) | |
 Anosmia and loss of taste | – | 48 (54.5%) | 40 (45.5%) | |
 Neurological | – | 23 (57.5%) | 17 (42.5%) | |
 Mixed | – | 74 (61.7%) | 46 (38.3%) | |
Severity of respiratory symptoms | 0.1 | |||
 Mild |  | 17 (51.5%) | 9 (69.2%) | |
 Moderate |  | 13 (39.4%) | 4 (30.8%) | |
 Severe |  | 3 (9.1%) | 0 (0%) | |
Mortality | ||||
Improvement | 47 (33.3%) | 69 (48.9%) | 25 (17.7%) | 0.2 |
Death | 20 (23%) | 53 (60.9%) | 14 (16.1%) |